Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Diabetic dyslipidaemia in Asian populations in the Western Pacific Region: what we know and don't know.

Chan JC, Chan SP, Deerochanawong C, Go RT, Lee KO, Ma RC, Pan CY, Sheu WH, Barter P.

Diabetes Res Clin Pract. 2011 Oct;94(1):1-13. doi: 10.1016/j.diabres.2011.05.034. Epub 2011 Jul 13. Review.

PMID:
21742396
2.

Cerebral perfusion and vascular reserve in fibromuscular dysplasia of the internal carotid artery.

Wong CY, Beven EG, Go RT.

J Stroke Cerebrovasc Dis. 1998 Sep-Oct;7(5):364-6.

PMID:
17895114
3.

On FDG PET metabolic imaging to assess myocardial viability.

Brunken RC, Go RT, MacIntyre WJ.

J Nucl Med. 2000 Apr;41(4):25N. No abstract available.

4.

Scintigraphic detection of post-pneumonectomy bronchopleural fistulae.

Raja S, Rice TW, Neumann DR, Saha GB, Khandekar S, MacIntyre WJ, Go RT.

Eur J Nucl Med. 1999 Mar;26(3):215-9.

PMID:
10079310
5.

Comparison of double-phase 99mTc-sestamibi with 123I-99mTc-sestamibi subtraction SPECT in hyperparathyroidism.

Neumann DR, Esselstyn CB Jr, Go RT, Wong CO, Rice TW, Obuchowski NA.

AJR Am J Roentgenol. 1997 Dec;169(6):1671-4.

PMID:
9393188
6.
7.

Viable neurons with luxury perfusion in hydrocephalus.

Wong CY, Luciano MG, MacIntyre WJ, Brunken RC, Hahn JF, Go RT.

J Nucl Med. 1997 Sep;38(9):1467-70.

8.

Preliminary experience with double-phase SPECT using Tc-99m sestamibi in patients with hyperparathyroidism.

Neumann DR, Esselstyn CB Jr, Kim EY, Go RT, Obuchowski NA, Rice TW.

Clin Nucl Med. 1997 Apr;22(4):217-21.

PMID:
9099475
9.

Myocardial viability studies using fluorine-18-FDG SPECT: a comparison with fluorine-18-FDG PET.

Chen EQ, MacIntyre WJ, Go RT, Brunken RC, Saha GB, Wong CY, Neumann DR, Cook SA, Khandekar SP.

J Nucl Med. 1997 Apr;38(4):582-6.

10.

A rapid chromatographic method for quality control of technetium-99m-bicisate.

Amin KC, Saha GB, Go RT.

J Nucl Med Technol. 1997 Mar;25(1):49-51.

PMID:
9239604
11.

Regional body FDG-PET in postoperative recurrent hyperparathyroidism.

Neumann DR, Esselstyn CB Jr, MacIntyre WJ, Chen EQ, Go RT, Licata AA.

J Comput Assist Tomogr. 1997 Jan-Feb;21(1):25-8.

PMID:
9022764
12.

Comparison of FDG-PET and sestamibi-SPECT in primary hyperparathyroidism.

Neumann DR, Esselstyn CB, Maclntyre WJ, Go RT, Obuchowski NA, Chen EQ, Licata AA.

J Nucl Med. 1996 Nov;37(11):1809-15.

13.

Present assessment of myocardial viability by nuclear imaging.

Saha GB, MacIntyre WJ, Brunken RC, Go RT, Raja S, Wong CO, Chen EQ.

Semin Nucl Med. 1996 Oct;26(4):315-35. Review.

PMID:
8916320
14.
15.

Measurement of cardiac output with first-pass determination during rubidium-82 PET myocardial perfusion imaging.

Chen EQ, MacIntyre WJ, Fouad FM, Brunken RC, Go RT, Wong CO, Saha GB, Dorosti K, Razavi M, Armstrong R.

Eur J Nucl Med. 1996 Aug;23(8):993-6.

PMID:
8753693
16.

Outcome of temporal lobe epilepsy surgery predicted by statistical parametric PET imaging.

Wong CY, Geller EB, Chen EQ, MacIntyre WJ, Morris HH 3rd, Raja S, Saha GB, L├╝ders HO, Cook SA, Go RT.

J Nucl Med. 1996 Jul;37(7):1094-100.

17.

The incidence of scintigraphically viable and nonviable tissue by rubidium-82 and fluorine-18-fluorodeoxyglucose positron emission tomographic imaging in patients with prior infarction and left ventricular dysfunction.

Go RT, MacIntyre WJ, Cook SA, Neumann DR, Brunken RC, Saha GB, Underwood DA, Marwick TH, Chen EQ, King JL, Khandekar S.

J Nucl Cardiol. 1996 Mar-Apr;3(2):96-104.

PMID:
8799234
18.

Malignant pheochromocytoma of the anterior mediastinum: PET findings with [18F]FDG and 82Rb.

Neumann DR, Basile KE, Bravo EL, Chen EQ, Go RT.

J Comput Assist Tomogr. 1996 Mar-Apr;20(2):312-6.

PMID:
8606245
19.

Use of positron emission tomography for prediction of perioperative and late cardiac events before vascular surgery.

Marwick TH, Shan K, Go RT, MacIntyre WJ, Lauer MS.

Am Heart J. 1995 Dec;130(6):1196-202.

PMID:
7484769
20.

Noninvasive carotid artery testing.

Wong CY, MacIntyre WJ, Go RT.

Ann Intern Med. 1995 Oct 15;123(8):633-4. No abstract available.

PMID:
7677309
21.

Hibernating myocardium versus scar: severity of irreversible decreased myocardial perfusion in prediction of tissue viability.

Go RT, MacIntyre WJ, Saha GB, Cook SA, Neumann DR, Chen EQ, Underwood DA, Kaczur T.

Radiology. 1995 Jan;194(1):151-5.

PMID:
7997543
22.

Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization.

Lee KS, Marwick TH, Cook SA, Go RT, Fix JS, James KB, Sapp SK, MacIntyre WJ, Thomas JD.

Circulation. 1994 Dec;90(6):2687-94.

PMID:
7994809
23.

Comparison of persistent thallium perfusion defects by quantitative washout analysis with thallium reinjection in patients with coronary artery disease.

Garcia MJ, Neumann D, Go RT, Ares MA, Rodriguez L, Griffin BP, Thomas JD.

Am J Cardiol. 1994 Nov 15;74(10):977-81.

PMID:
7977057
24.

Radiopharmaceuticals for brain imaging.

Saha GB, MacIntyre WJ, Go RT.

Semin Nucl Med. 1994 Oct;24(4):324-49. Review.

PMID:
7817203
25.

Primary hyperparathyroidism: preoperative parathyroid imaging with regional body FDG PET.

Neumann DR, Esselstyn CB Jr, MacIntyre WJ, Chen EQ, Go RT, Kohse LM, Licata AA.

Radiology. 1994 Aug;192(2):509-12.

PMID:
8029424
26.

Current status of the clinical applications of cardiac positron emission tomography.

Go RT, MacIntyre WJ, Chen EQ, Cook SA, Neumann DR, Saha GB.

Radiol Clin North Am. 1994 May;32(3):501-19. Review.

PMID:
8184026
27.

Planar imaging with single-head large-field-of-view cameras: are they still the workhorse?

MacIntyre WJ, Saha GB, Go RT.

Semin Nucl Med. 1994 Jan;24(1):11-6. Review.

PMID:
8122125
28.

Parametric phase display for biventricular function from gated cardiac blood pool single-photon emission tomography.

Neumann DR, Go RT, Myers BA, MacIntyre WJ, Chen EQ, Cook SA.

Eur J Nucl Med. 1993 Nov;20(11):1108-11.

PMID:
8287880
29.

Parathyroid adenoma localization by PET FDG.

Neumann DR, Esselstyn CB, MacIntyre WJ, Chen EQ, Go RT, Kohse LM.

J Comput Assist Tomogr. 1993 Nov-Dec;17(6):976-7.

PMID:
8227589
30.

Pulmonary embolism: increased ventilation in areas of decreased perfusion.

Go RT, MacIntyre WJ, Meziane MA, Lammert GK, Cook SA, Neumann DR.

Radiology. 1993 Apr;187(1):51-4.

PMID:
8451436
31.

Clinical outcome of cardiac patients with negative thallium-201 SPECT and positive rubidium-82 PET myocardial perfusion imaging.

MacIntyre WJ, Go RT, King JL, Cook SA, Neumann DR, Saha GB, Antar MA.

J Nucl Med. 1993 Mar;34(3):400-4.

32.

Does PET offer little additional value when compared with SPECT?

MacIntyre WJ, Go RT, Cook SA.

J Nucl Med. 1992 Aug;33(8):1586; author reply 1587-8. No abstract available.

33.

Myocardial perfusion imaging in the diagnosis of coronary artery disease.

Go RT, MacIntyre WJ, Cook SA, Neumann DR.

Curr Opin Radiol. 1992 Aug;4(4):23-33. Review.

PMID:
1627448
34.

Cyclotrons and positron emission tomography radiopharmaceuticals for clinical imaging.

Saha GB, MacIntyre WJ, Go RT.

Semin Nucl Med. 1992 Jul;22(3):150-61. Review.

PMID:
1523413
35.
36.

Radiopharmaceucticals for cardiovascular imaging.

Saha GB, Go RT, MacIntyre WJ.

Int J Rad Appl Instrum B. 1992 Jan;19(1):1-20. Review.

PMID:
1577608
37.

Atrial natriuretic factor and catecholamine levels during exercise in patients with and without coronary artery disease.

Robalino BD, Petrella RW, Salcedo EE, Go RT, Bravo EL.

Cleve Clin J Med. 1991 Nov-Dec;58(6):493-9.

PMID:
1836423
38.

Whither, or wither nuclear medicine?

MacIntyre WJ, Go RT.

Adm Radiol. 1991 Nov;10(11):78-80, 83.

PMID:
10115725
39.
40.

Identification of ischemic and hibernating myocardium: feasibility of post-exercise F-18 deoxyglucose positron emission tomography.

Marwick TH, MacIntyre WJ, Salcedo EE, Go RT, Saha G, Beachler A.

Cathet Cardiovasc Diagn. 1991 Feb;22(2):100-6.

PMID:
2009557
41.
42.

Left ventricular hypertrophy sensitizes the myocardium to the development of ischaemia.

Salcedo EE, Marwick TH, Korzick DH, Goormastic M, Go RT.

Eur Heart J. 1990 Nov;11 Suppl G:72-8.

PMID:
2150039
43.

The incorporation of tibial allografts in total knee arthroplasty.

Wilde AH, Schickendantz MS, Stulberg BN, Go RT.

J Bone Joint Surg Am. 1990 Jul;72(6):815-24.

PMID:
2365715
44.

A simple and accurate grading system for orthoiodohippurate renal scans in the assessment of post-transplant renal function.

Zaki SK, Bretan PN, Go RT, Rehm PK, Streem SB, Novick AC.

J Urol. 1990 Jun;143(6):1099-102.

PMID:
2342167
45.

Ineffectiveness of dipyridamole SPECT thallium imaging as a screening technique for coronary artery disease in patients with end-stage renal failure.

Marwick TH, Steinmuller DR, Underwood DA, Hobbs RE, Go RT, Swift C, Braun WE.

Transplantation. 1990 Jan;49(1):100-3.

PMID:
2300998
46.

Use of the 82Sr/82Rb generator in clinical PET studies.

Saha GB, Go RT, MacIntyre WJ, Marwick TH, Beachler A, King JL, Neumann DR.

Int J Rad Appl Instrum B. 1990;17(8):763-8.

PMID:
2079423
47.

Conditions of radioiodination with iodogen as oxidizing agent.

Saha GB, Whitten J, Go RT.

Int J Rad Appl Instrum B. 1989;16(4):431-3.

PMID:
2777585
48.

Gd-DISIDA--a potential contrast agent for magnetic resonance imaging of the hepatobiliary system.

Saha GB, Bateson BP, Meaney TF, Ng TC, Go RT, MacIntyre WJ, Feiglin DH, O'Donnell JK.

J Nucl Med Allied Sci. 1989 Jan-Mar;33(1):1-6.

PMID:
2746364
49.

Different cell moieties and white blood cell (WBC) integrity in 111In labeled WBC preparations.

Saha GB, Feiglin DH, Karam PM, McMahon JT, Go RT, O'Donnell JK, MacIntyre WJ.

J Nucl Med Allied Sci. 1987 Apr-Jun;31(2):201-5. No abstract available.

PMID:
3114441
50.

Congenital dysplastic left ventricle simulating anomalous origin of the left coronary artery.

Moodie DS, Ben-Shachar G, Sterba R, Go RT, Ratliff NB.

Cleve Clin Q. 1986 Spring;53(1):99-103. No abstract available.

PMID:
3708852

Supplemental Content

Support Center